Chinese Rulemaking Escalates Crackdown on Pharma Corruption

Drug Industry Daily
A drugmaker convicted of bribery in China will have its products barred from being purchased by private and government-funded organizations for two years in the province where it is convicted. A second offense within five years will result in a two-year, nationwide ban.

To View This Article:


Subscribe To Drug Industry Daily